Correlation Between Y MAbs and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Y MAbs and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Y MAbs and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Y mAbs Therapeutics and Mersana Therapeutics, you can compare the effects of market volatilities on Y MAbs and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Y MAbs with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Y MAbs and Mersana Therapeutics.
Diversification Opportunities for Y MAbs and Mersana Therapeutics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between YMAB and Mersana is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Y mAbs Therapeutics and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Y MAbs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Y mAbs Therapeutics are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Y MAbs i.e., Y MAbs and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Y MAbs and Mersana Therapeutics
Given the investment horizon of 90 days Y mAbs Therapeutics is expected to under-perform the Mersana Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Y mAbs Therapeutics is 1.71 times less risky than Mersana Therapeutics. The stock trades about -0.19 of its potential returns per unit of risk. The Mersana Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 187.00 in Mersana Therapeutics on August 31, 2024 and sell it today you would earn a total of 32.00 from holding Mersana Therapeutics or generate 17.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Y mAbs Therapeutics vs. Mersana Therapeutics
Performance |
| Timeline |
| Y mAbs Therapeutics |
| Mersana Therapeutics |
Y MAbs and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Y MAbs and Mersana Therapeutics
The main advantage of trading using opposite Y MAbs and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Y MAbs position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| Y MAbs vs. Revolution Medicines | Y MAbs vs. Black Diamond Therapeutics | Y MAbs vs. Passage Bio | Y MAbs vs. Bluebird bio |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |